Jon Laing Cholangiocarcinoma Survivor
Jon’s journey with cholangiocarcinoma is a testament to resilience and determination. Nearing her five-year milestone, she shares the strength that has kept her fighting.
Sandra Robertson cholangiocarcinoma survivor
Sandra's survival story shows how patient-led decisions, clarity, and faith turned a rare diagnosis into a five-year survival milestone.
Lynette Williams Cholangiocarcinoma Journey
Lynette and John Williams cholangiocarcinoma story of early detection, liver resection, recurrence and structured response under pressure.
Joe & Tegan’s Cholangiocarcinoma Journey
Joe and Tegan’s cholangiocarcinoma story shows how truth, ownership and response can change trajectory through diagnosis, crisis and recurrence.
Jill Brown Cholangiocarcinoma | Podcast on losing her daughter Catie
Listen to the Jill Brown cholangiocarcinoma podcast as she shares losing her daughter Catie at 22 and reflects on grief and resilience.
Bridging Funding Australia Why Approved Medicines Take 466 Days to Reach Patients
Australia approves medicines that patients cannot access for an average of 466 days. This article explains why the delay exists, what bridging funding is, and why it matters to patients and caregivers.
Jon Laing Cholangiocarcinoma Survivor
Jon’s journey with cholangiocarcinoma is a testament to resilience and determination. Nearing her five-year milestone, she shares the strength that has kept her fighting.
Sandra Robertson cholangiocarcinoma survivor
Sandra's survival story shows how patient-led decisions, clarity, and faith turned a rare diagnosis into a five-year survival milestone.
Lynette Williams Cholangiocarcinoma Journey
Lynette and John Williams cholangiocarcinoma story of early detection, liver resection, recurrence and structured response under pressure.
Joe & Tegan’s Cholangiocarcinoma Journey
Joe and Tegan’s cholangiocarcinoma story shows how truth, ownership and response can change trajectory through diagnosis, crisis and recurrence.
Jill Brown Cholangiocarcinoma | Podcast on losing her daughter Catie
Listen to the Jill Brown cholangiocarcinoma podcast as she shares losing her daughter Catie at 22 and reflects on grief and resilience.
Bridging Funding Australia Why Approved Medicines Take 466 Days to Reach Patients
Australia approves medicines that patients cannot access for an average of 466 days. This article explains why the delay exists, what bridging funding is, and why it matters to patients and caregivers.
